Gastroesophageal Reflux Disease Market Share

Market Share of Gastroesophageal Reflux Disease Industry

The gastroesophageal reflux disease market is fragmented in nature owing to the presence of several market players. The market players are engaged in strategic initiatives such as mergers, acquisitions, product approvals, and launches to expand their presence. Some of the market players are Pfizer, Inc., Johnson & Johnson, SRS Life Sciences, Takeda Pharmaceutical Co., Ltd., and Haleon Group of Companies.

Gastroesophageal Reflux Disease (GERD) Market Leaders

1. Pfizer, Inc.

2. Johnson & Johnson

3. SRS Life Sciences

4. Takeda Pharmaceutical Co., Ltd.

5. Haleon Group of Companies

*Disclaimer: Major Players sorted in no particular order